BFM
PRQR icon

Boothbay Fund Management’s ProQR Therapeutics PRQR Stock Holding History

Boothbay Fund Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$576K Hold
355,283
– – 0.01% 1266
2025
Q4 		$718K Buy
355,283
+106,993
+43% +$250K 0.01% 956
2025
Q3 		$529K Buy
248,290
+24,160
+11% +$52.8K 0.01% 1121
2025
Q2 		$457K Hold
224,130
– – 0.01% 934
2025
Q1 		$298K Sell
224,130
-36,146
-14% -$76.9K 0.01% 1063
2024
Q4 		$690K Buy
260,276
+153,573
+144% +$488K 0.02% 762
2024
Q3 		$194K Hold
106,703
– – ﹤0.01% 1402
2024
Q2 		$177K Hold
106,703
– – ﹤0.01% 1305
2024
Q1 		$244K Buy
106,703
+10,958
+11% +$23.4K ﹤0.01% 1272
2023
Q4 		$190K Hold
95,745
– – ﹤0.01% 1344
2023
Q3 		$124K Hold
95,745
– – ﹤0.01% 1520
2023
Q2 		$155K Hold
95,745
– – ﹤0.01% 1537
2023
Q1 		$204K Buy
95,745
+5,460
+6% +$16.7K ﹤0.01% 1735
2022
Q4 		$334K Buy
+90,285
New +$118K 0.01% 1338
2021
Q4 		– Sell
-18,191
Closed -$152K – 2147
2021
Q3 		$152K Sell
18,191
-20,217
-53% -$132K ﹤0.01% 1669
2021
Q2 		$259K Buy
+38,408
New +$248K 0.01% 1374
2020
Q1 		– Sell
-36,051
Closed -$357K – 1010
2019
Q4 		$357K Buy
+36,051
New +$281K 0.03% 572

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Boothbay Fund Management's PRQR Position: Q1 2026 in Review

Boothbay Fund Management held its ProQR Therapeutics (PRQR) position steady in Q1 2026 at 355,283 shares worth $576K. The position accounts for 0.01% of the portfolio, ranked #1266.

Boothbay Fund Management first reported a position in PRQR in Q4 2019 and has held it in 17 quarters since. The position peaked at $718K in Q4 2025. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • Boothbay Fund Management held 355,283 shares of ProQR Therapeutics worth $576K as of Q1 2026.
  • Boothbay Fund Management left its ProQR Therapeutics share count unchanged in Q1 2026.
  • ProQR Therapeutics made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1266 holding.
  • Boothbay Fund Management first reported a position in ProQR Therapeutics in Q4 2019 and has held it in 17 quarters since.
  • Boothbay Fund Management's ProQR Therapeutics position peaked at $718K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.